In a new preclinical study, a Northwestern Medicine® scientist has isolated the motor neurons in the brain that die in ALS and, for the first time, dressed them in a green fluorescent jacket. As a result, scientists will now be able to track what goes wrong in these cells to cause their deaths and be able to search for effective treatments.
Browsing: Marla Paul
Within the next few decades, getting a new kidney could be as simple as having a doctor order an engineered organ that will be developed in the laboratory with a patient’s own cells. Delivery could take a few months and, theoretically, a patient might not need immunosuppressant drugs because his body would recognize the kidney as his own.
A Northwestern Medicine® study has found Chicago’s Neighbor Carts pilot program last year was profitable for the vendors selling fresh produce and a boon for customers buying fruit, vegetables, and nuts. It was so successful, in fact, that this year the program will expand from eight to 30 carts, with new ones rolling out this month.
The cholera strain that transferred to Haiti in 2010 has multiple toxin gene mutations that may account for the severity of disease and is evolving to be more like an 1800s version of cholera, reports a new Northwestern Medicine® study.
Systemic sclerosis, also known as scleroderma, is a rare autoimmune connective tissue disorder that’s difficult to treat. However, thanks to new research at Northwestern University Feinberg School of Medicine and Dartmouth’s Geisel School of Medicine, doctors may be able to treat some patients more effectively.
A new gentler chemotherapy drug in the form of nanoparticles has been designed by Northwestern Medicine scientists to be less toxic to a young woman’s fertility but extra tough on cancer. This is the first cancer drug tested while in development for its effect on fertility using a novel in vitro test.
Allaying previous concerns, a Northwestern Medicine® scientist found that an infant’s growth was not impacted by its mother taking selective serotonin reuptake inhibitor antidepressants during pregnancy.
A newly identified set of genes may predict which women are at high risk for getting breast cancer that is sensitive to estrogen and, therefore, would be helped by taking drugs to prevent it, reports a new Northwestern Medicine® study.
Led by Katherine L. Wisner, MD, the large-scale study screened 10,000 women who had recently delivered infants for depression and found that a large percentage suffered recurring episodes.
In the first large-scale longitudinal study of obsessive-compulsive symptoms in the postpartum period, a new Northwestern Medicine® study found 11 percent of women at two weeks and six months postpartum experience significant obsessive-compulsive symptoms compared to 2 to 3 percent in the general population.